Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains.

scientific article published in May 1988

Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID3360782

P2093author name stringWu CS
Weisgraber KH
Lindgren FT
Wetterau JR
Aggerbeck LP
P433issue13
P407language of work or nameEnglishQ1860
P1104number of pages10
P304page(s)6249-6258
P577publication date1988-05-01
P1433published inJournal of Biological ChemistryQ867727
P1476titleHuman apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains
P478volume263

Reverse relations

cites work (P2860)
Q42127354A gel-based method for purification of apolipoprotein A-I from small volumes of plasma.
Q38154771A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy.
Q34034409APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease
Q34210015Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target
Q91779698Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation
Q34729047Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease
Q42049013Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges
Q34497951Apolipoprotein E: From lipid transport to neurobiology
Q28265290Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease
Q47270627Atomistic Insights into Structural Differences between E3 and E4 Isoforms of Apolipoprotein E.
Q34662682Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease
Q41854389Biochemical and biophysical characterization of recombinant rat apolipoprotein E: similarities to human apolipoprotein E3.
Q28477741Biophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemia
Q37216782Biophysical analysis of progressive C-terminal truncations of human apolipoprotein E4: insights into secondary structure and unfolding properties
Q53859365Cloning and sequencing of bovine apolipoprotein E complementary DNA and molecular evolution of apolipoproteins E, C-I, and C-II.
Q41836439Concerning the structure of apoE
Q27624879Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: Implications for lipid binding
Q42216886Dimyristoylphosphotidylcholine induces conformational changes in apoB that lowers lipoprotein(a).
Q41973817Dissociation of apolipoprotein E oligomers to monomer is required for high-affinity binding to phospholipid vesicles
Q35031146Domains of apoE4 required for the biogenesis of apoE-containing HDL.
Q38702378Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.
Q34951817Function and comorbidities of apolipoprotein e in Alzheimer's disease
Q35001010HDL mimetic peptide ATI-5261 forms an oligomeric assembly in solution that dissociates to monomers upon dilution
Q35547011High density lipoprotein structure-function and role in reverse cholesterol transport
Q42086925High- and low-temperature unfolding of human high-density apolipoprotein A-2.
Q35456689Hydrogen/deuterium exchange and electron-transfer dissociation mass spectrometry determine the interface and dynamics of apolipoprotein E oligomerization
Q37149489Insight on the molecular envelope of lipid-bound apolipoprotein E from electron paramagnetic resonance spectroscopy.
Q28508278Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E
Q35226230Mass spectrometry-based protein footprinting characterizes the structures of oligomeric apolipoprotein E2, E3, and E4.
Q39978471Mechanism of Lipid Binding of Human Apolipoprotein E3 by Hydrogen/Deuterium Exchange/Mass Spectrometry and Fluorescence Polarization.
Q36915632Modification by acrolein, a component of tobacco smoke and age-related oxidative stress, mediates functional impairment of human apolipoprotein E.
Q33556316Molecular basis for increased risk for late-onset Alzheimer disease due to the naturally occurring L28P mutation in apolipoprotein E4.
Q34395148Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4
Q39965041N-methyl-D-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein
Q36281647NMR studies of the low-density lipoprotein receptor-binding peptide of apolipoprotein E bound to dodecylphosphocholine micelles
Q57024078Ordered opening of LDL receptor binding domain of human apolipoprotein E3 revealed by hydrogen/deuterium exchange mass spectrometry and fluorescence spectroscopy
Q42816401Orientation and mode of lipid-binding interaction of human apolipoprotein E C-terminal domain
Q39781531Role of the N- and C-terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study.
Q37297851Semisynthesis and segmental isotope labeling of the apoE3 N-terminal domain using expressed protein ligation
Q40168878Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid beta-peptide with the N-terminal, receptor binding domain of apolipoprotein E.
Q34499744Structural and functional characterization of human apolipoprotein E 72-166 peptides in both aqueous and lipid environments
Q41973597Structural differences between apolipoprotein E3 and E4 as measured by (19)F NMR.
Q33828806Swapping the N- and C-terminal domains of human apolipoprotein E3 and AI reveals insights into their structure/activity relationship
Q41836527The Association−Dissociation Behavior of the ApoE Proteins: Kinetic and Equilibrium Studies
Q33946941The N-terminus of apolipoprotein A-V adopts a helix bundle molecular architecture
Q37141330The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific.
Q41912071The extent of pyrene excimer fluorescence emission is a reflector of distance and flexibility: analysis of the segment linking the LDL receptor-binding and tetramerization domains of apolipoprotein E3.
Q33598704The helix bundle: a reversible lipid binding motif
Q36462050Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy
Q57476233Thermodynamic destabilization and aggregation propensity as the underlying mechanism behind the genetic association of apoE3 mutants and Lipoprotein Glomerulopathy
Q27672294Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions
Q37307244Understanding the association of apolipoprotein E4 with Alzheimer disease: clues from its structure

Search more.